RSS   Newsletter   Contact   Advertise with us
Post Online Media

Richard D. Katz joins Argos Therapeutics as CFO

Richard D. KatzArgos Therapeutics, Inc., an immuno-oncology company, announced that Richard D. Katz has joined the company as chief financial officer.

Dr. Katz comes to Argos with more than 20 years of experience in healthcare finance and corporate development. Most recently, Dr. Katz served as chief financial officer for Viamet Pharmaceuticals, Inc.

Previously, Dr. Katz served as chief financial officer for Icagen, Inc., where he was instrumental in the company's initial public offering and subsequent financings, the formation of several strategic collaborations, and the company's sale to Pfizer.

Prior to Icagen, he worked as a vice president in the healthcare group at Goldman, Sachs & Company, where he executed a broad range of transactions, including equity and debt financings, mergers and acquisitions, and corporate restructurings.

Dr. Katz received his A.B. magna cum laude from Harvard University, his M.D. from the Stanford University School of Medicine and his M.B.A. from Harvard Business School, where he graduated as a Baker Scholar.

 LATEST MOVES FROM North Carolina 

More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy